Cargando…

Therapeutic Potential of Glutamine Pathway in Lung Cancer

Cancer cells tend to obtain the substances needed for their development depending on altering metabolic characteristics. Among the reorganized metabolic pathways, Glutamine pathway, reprogrammed to be involved in the physiological process including energy supply, biosynthesis and redox homeostasis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Enyu, Liu, Siyang, Zhang, Zhiming, Zhang, Rixin, Huang, Dejing, Gao, Tong, Zhang, Tianze, Xu, Guangquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873175/ https://www.ncbi.nlm.nih.gov/pubmed/35223460 http://dx.doi.org/10.3389/fonc.2021.835141

Ejemplares similares

Metabolomic and Transcriptomic Profiling Identified Significant Genes in Thymic Epithelial Tumor
por: Tang, Enyu, et al.
Publicado: (2022)

Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment
por: Huang, Dejing, et al.
Publicado: (2022)

Rhophilin-2 Upregulates Glutamine Synthetase by Stabilizing c-Myc Protein and Confers Resistance to Glutamine Deprivation in Lung Cancer
por: Xiao, Dakai, et al.
Publicado: (2021)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
por: Duan, Wenrui, et al.
Publicado: (2014)

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
por: He, Songjiang, et al.
Publicado: (2022)

The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer
por: Burgess, Joshua T., et al.
Publicado: (2020)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
por: Li, Hui, et al.
Publicado: (2023)

Microarray Identifies a Key Carcinogenic Circular RNA 0008594 That Is Related to Non-Small-Cell Lung Cancer Development and Lymph Node Metastasis and Promotes NSCLC Progression by Regulating the miR-760-Mediated PI3K/AKT and MEK/ERK Pathways
por: Wang, Qiushi, et al.
Publicado: (2021)

Glutamine synthetase expression rescues human dendritic cell survival in a glutamine-deprived environment
por: Schoeppe, Robert, et al.
Publicado: (2023)

Glutamine metabolism in cancers: Targeting the oxidative homeostasis
por: Gong, Tengfang, et al.
Publicado: (2022)

Glutamine Addiction and Therapeutic Strategies in Lung Cancer
por: Vanhove, Karolien, et al.
Publicado: (2019)

Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma
por: Chen, Qianhui, et al.
Publicado: (2022)

Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
por: Zheng, Yue, et al.
Publicado: (2022)

Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth
por: Scalise, Mariafrancesca, et al.
Publicado: (2017)

Gas6/AXL pathway: immunological landscape and therapeutic potential
por: Zhai, Xiaoqian, et al.
Publicado: (2023)

Deferoxamine Counteracts Cisplatin Resistance in A549 Lung Adenocarcinoma Cells by Increasing Vulnerability to Glutamine Deprivation-Induced Cell Death
por: Liu, Wen-Jun, et al.
Publicado: (2022)

Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer
por: Gao, Min, et al.
Publicado: (2023)

The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer
por: Bian, Xing, et al.
Publicado: (2020)

Glutamine metabolism and radiosensitivity: Beyond the Warburg effect
por: Alden, Ryan S., et al.
Publicado: (2022)

Transcription Factor p53 Suppresses Tumor Growth by Prompting Pyroptosis in Non-Small-Cell Lung Cancer
por: Zhang, Tianze, et al.
Publicado: (2019)

Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer
por: Bian, Xing, et al.
Publicado: (2023)

Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review)
por: Zhou, Lei, et al.
Publicado: (2023)

Editorial: Biomarkers, functional mechanisms, and therapeutic potentials in gastrointestinal cancers
por: Huang, Jun, et al.
Publicado: (2023)

The Hippo pathway in endometrial cancer: a potential therapeutic target?
por: Shen, Xinyun, et al.
Publicado: (2023)

Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
por: Zha, Cheng, et al.
Publicado: (2023)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
por: Demas, Diane M., et al.
Publicado: (2019)

Advanced diagnostic and therapeutic strategies in nanotechnology for lung cancer
por: Duan, Yujuan, et al.
Publicado: (2022)

Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
por: He, Zehua, et al.
Publicado: (2023)

Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis
por: Guo, Yaru, et al.
Publicado: (2021)

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

Adipocytic Glutamine Synthetase Upregulation via Altered Histone Methylation Promotes 5FU Chemoresistance in Peritoneal Carcinomatosis of Colorectal Cancer
por: Zhang, Xuan, et al.
Publicado: (2021)

Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors
por: Xia, Qin, et al.
Publicado: (2020)

Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023)

Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2020)

New progress of glutamine metabolism in the occurrence, development, and treatment of ovarian cancer from mechanism to clinic
por: Yang, Xiaojing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k21p8oifnjn74fom1j0dhp5ie8